Results 81 to 90 of about 894,794 (275)

Botulinum toxin in muscle spasticity [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 2000
Botulinum toxin type A has been widely used in focal dystonias for more than 10 years, but it is also undoubtedly of benefit in the relief of spasticity,1 a far commoner cause of motor impairment and neurological disability. The injection technique, by contrast with more traditional peripheral nerve blocks, requires little special equipment and can be ...
openaire   +1 more source

Exteroceptive Reflexes in Stiff Person Syndrome, Other Neurological Conditions and Healthy Controls

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Stiff person syndrome (SPS) is a rare disabling neurological condition with overlapping symptomatology with more common neurological conditions. Exaggerated exteroceptive reflex mechanisms are thought to play a role in its pathophysiology.
Belinda Cruse   +8 more
wiley   +1 more source

Breathe, Eat, Talk: Three Essential Ingredients to Quality‐of‐Life Outcomes in Movement Disorders

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Breathing, eating, and talking (BET) impairments are common yet frequently underrecognized features of movement disorders. Deficits in respiration, swallowing, voice, and speech may emerge early in the course of a disease, adversely affecting safety, participation, and quality of life.
John Dean   +16 more
wiley   +1 more source

Research Progress of Radial Extracorporeal Shock Wave Therapy for Post-Stroke Spasticity

open access: yes康复学报
One of the common complications in stroke patients is muscle spasticity, which not only seriously affects the patient's motor ability, but can also may lead to sensory disturbance, persistent pain, muscle stiffness, reduced range of motion of the joints,
WU Zongqian, BAI Dingqun
doaj  

EEG findings in SERAC1‐related MEGD(H)EL syndrome

open access: yes
Epileptic Disorders, EarlyView.
Apurva Patel, Dalila Lewis, Thomas Koch
wiley   +1 more source

JAK2 Variant and Parkinsonian Syndromes: Coincidence or Pathophysiological Link?

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background JAK2 variants are a hallmark of myeloproliferative neoplasms (MPNs), including polycythemia vera and essential thrombocythemia. These disorders are often associated with thrombotic and inflammatory complications. From a movement disorder perspective, chorea is a rare but well‐recognized neurological occurrence in this context ...
Elena Ardila Jurado   +5 more
wiley   +1 more source

Recent Advances in Exosome‐Based Nanodelivery Systems for Traumatic Brain Injury Treatment

open access: yesMed Research, EarlyView.
An overview of functional modification, therapeutic effects, molecular composition, and delivery strategies for exosomes. ABSTRACT Traumatic brain injury (TBI) is a highly heterogeneous neurological condition with extremely high rates of mortality and disability.
Jue Zhu   +9 more
wiley   +1 more source

Key Interventions in Friedreich's Ataxia and Their Impact on Patient Outcomes: A Systematic Review

open access: yesMovement Disorders, EarlyView.
Abstract Friedreich's ataxia (FA) is a rare neurodegenerative disease with multisystemic symptoms that requires multidisciplinary care. This systematic review summarizes available pharmacological and nonpharmacological interventions, their outcomes, and alignment with patient‐centered care domains, as well as their impact on these domains.
Dorota Sarwinska   +6 more
wiley   +1 more source

Applications of bio-feedback to muscle models

open access: yes, 2011
An EMG-driven musculoskeletal model is implemented to estimate subject-specific musculoskeletal parameters such as the optimal physiological muscle length, the tendon slack length and the maximum isometric muscle force of flexor and extensor muscle ...
Mace, B.R., Colacino, F.M., Rustighi, E.
core   +1 more source

Muscle-Specific Dosing of OnabotulinumtoxinA in Post-Stroke Upper-Limb Spasticity: A Descriptive Literature Review

open access: yesToxins
Background: Botulinum neurotoxin type A is widely used in the management of post-stroke upper-limb spasticity; however, many studies report total injected doses rather than muscle-specific dosing, limiting clinical applicability.
Małgorzata Cisowska-Adamiak   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy